Vaginal administration of estradiol: effects of dose, preparation and timing on plasma estradiol levels.
about
New evidence for cardiac benefit of postmenopausal hormone therapy.Shape-Memory Terpolymer Rods with 17-β-estradiol for the Treatment of Neurodegenerative Diseases: an In Vitro and In Vivo StudyIntravaginally applied oxytocin improves post-menopausal vaginal atrophy.Bone mineral density is associated with vitamin D related rs6013897 and estrogen receptor polymorphism rs4870044: The Tromsø study.Pharmacokinetic studies of solubilized estradiol given vaginally in a novel softgel capsule.Breast cancer, endometrial cancer, and cardiovascular events in participants who used vaginal estrogen in the Women's Health Initiative Observational Study.Vaginal Health During Breast Cancer Treatment.Local hormone therapy for genitourinary syndrome of menopause in breast cancer patients: is it safe?Vaginal estradiol use and the risk for cardiovascular mortality.Safety issues associated with using medication to treat overactive bladder.Psychosexual health in gynecological cancer.A randomized, multicenter, double-blind study to evaluate the safety and efficacy of estradiol vaginal cream 0.003% in postmenopausal women with dyspareunia as the most bothersome symptom.A Randomized, Multicenter, Double-Blind, Study to Evaluate the Safety and Efficacy of Estradiol Vaginal Cream 0.003% in Postmenopausal Women with Vaginal Dryness as the Most Bothersome Symptom.Bioidentical menopausal hormone therapy: registered hormones (non-oral estradiol ± progesterone) are optimal.Prevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes: ESMO Clinical Practice Guidelines for cancer prevention and screening†
P2860
Q30396979-2E403098-0D66-44AD-A8F4-059A0713A24AQ31130788-7470A08F-C90E-4F43-8B44-69E68D7034FBQ36049247-BA4DB4A4-40FD-42AE-AA96-514208185F0EQ36295335-BCEFCC17-8782-41DC-A81F-880983A342FBQ36762596-A930A4B0-95DC-4256-8507-9839BAEA693AQ38620327-305919D1-5724-4FA0-856E-7381149EABCCQ38807445-93447AA6-AD6A-4830-B15B-B78509F531F0Q39170418-C2088D15-1655-473F-90EA-BD534A755B3CQ39999161-52683AD0-60BC-4EF4-A922-48F58DE4F9DFQ40058585-6D8F829A-992B-4E8F-A038-43E0817AAEC5Q41266890-123436D5-BC15-476C-840D-ADF31A43F9B9Q45067756-896B3D41-E1A2-4466-98AA-3116131F4CABQ45074478-A2CBA565-39F3-42C0-9C23-682A5C548626Q55060038-4AAFA00C-92B4-4D52-BDC4-A0376EBE2163Q59273721-89D00DEB-9019-483D-A1E6-F6F59C757257
P2860
Vaginal administration of estradiol: effects of dose, preparation and timing on plasma estradiol levels.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Vaginal administration of estr ...... ng on plasma estradiol levels.
@ast
Vaginal administration of estr ...... ng on plasma estradiol levels.
@en
type
label
Vaginal administration of estr ...... ng on plasma estradiol levels.
@ast
Vaginal administration of estr ...... ng on plasma estradiol levels.
@en
prefLabel
Vaginal administration of estr ...... ng on plasma estradiol levels.
@ast
Vaginal administration of estr ...... ng on plasma estradiol levels.
@en
P1433
P1476
Vaginal administration of estr ...... ng on plasma estradiol levels.
@en
P2093
R J Santen
P304
P356
10.3109/13697137.2014.947254
P577
2014-10-18T00:00:00Z